Metropolitan Life Insurance Company (MetLife)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,963
Closed -$46K 2776
2021
Q4
$46K Buy
16,963
+2,285
+16% +$6.19K ﹤0.01% 2708
2021
Q3
$65.5K Sell
14,678
-11,111
-43% -$49.6K ﹤0.01% 2721
2021
Q2
$150K Buy
25,789
+2,143
+9% +$12.4K ﹤0.01% 2365
2021
Q1
$166K Sell
23,646
-2,451
-9% -$17.2K ﹤0.01% 2148
2020
Q4
$125K Buy
26,097
+618
+2% +$2.97K ﹤0.01% 2235
2020
Q3
$149K Buy
25,479
+2,017
+9% +$11.8K ﹤0.01% 1966
2020
Q2
$158K Buy
23,462
+7,912
+51% +$53.4K ﹤0.01% 1964
2020
Q1
$98.9K Hold
15,550
﹤0.01% 2037
2019
Q4
$162K Buy
15,550
+37
+0.2% +$386 ﹤0.01% 2055
2019
Q3
$61K Hold
15,513
﹤0.01% 2479
2019
Q2
$231K Hold
15,513
﹤0.01% 1808
2019
Q1
$385K Hold
15,513
0.01% 1460
2018
Q4
$279K Hold
15,513
0.01% 1593
2018
Q3
$456K Hold
15,513
0.01% 1442
2018
Q2
$705K Buy
15,513
+1,174
+8% +$53.4K 0.01% 1101
2018
Q1
$757K Buy
14,339
+201
+1% +$10.6K 0.01% 1034
2017
Q4
$961K Sell
14,138
-15,156
-52% -$1.03M 0.01% 913
2017
Q3
$2.41M Hold
29,294
0.02% 877
2017
Q2
$2.74M Buy
29,294
+3,845
+15% +$360K 0.02% 860
2017
Q1
$1.62M Buy
25,449
+1,883
+8% +$120K 0.01% 1030
2016
Q4
$1.05M Sell
23,566
-798
-3% -$35.5K 0.01% 1273
2016
Q3
$878K Buy
24,364
+318
+1% +$11.5K 0.01% 1360
2016
Q2
$330K Buy
24,046
+4,795
+25% +$65.8K ﹤0.01% 1960
2016
Q1
$370K Hold
19,251
﹤0.01% 1775
2015
Q4
$674K Sell
19,251
-308
-2% -$10.8K 0.01% 1431
2015
Q3
$1.8M Buy
19,559
+1,361
+7% +$125K 0.01% 950
2015
Q2
$1.6M Sell
18,198
-1,010
-5% -$88.7K 0.01% 1051
2015
Q1
$1.43M Hold
19,208
0.01% 1027
2014
Q4
$1.08M Hold
19,208
0.01% 1287
2014
Q3
$871K Hold
19,208
0.01% 1363
2014
Q2
$795K Buy
19,208
+4,537
+31% +$188K 0.01% 1512
2014
Q1
$1.02M Hold
14,671
0.01% 1339
2013
Q4
$884K Buy
14,671
+1,722
+13% +$104K 0.01% 1408
2013
Q3
$787K Buy
12,949
+2,024
+19% +$123K 0.01% 1442
2013
Q2
$732K Buy
+10,925
New +$732K 0.01% 1436